Skip to main content
. Author manuscript; available in PMC: 2015 Jun 15.
Published in final edited form as: Bioorg Med Chem Lett. 2014 Apr 29;24(12):2613–2616. doi: 10.1016/j.bmcl.2014.04.081

Table 2.

Indoline-based agonists.

graphic file with name nihms590655u2.jpg
Cmpd R n EC50 (μM)a % VUAA1 efficacyb
6a (VUAA1) N/A 35.1 100 %
7a H 1 - No agonism
7b Br 1 21.5 82%
7c F 1 - No agonism
7d Methyl 1 - No agonism
7e Ethyl 1 38.6 128%
7f Methoxy 1 - No agonism
7g N,N-dimethylamino 1 - No agonism
7h Isopropyl 1 - No agonism
7i Tertbutyl 1 - No agonism
7j graphic file with name nihms590655t1.jpgc 47.6 71%
7k Br 2 - No agonism
a

Mean result of 4 experiments.

b

Maximum agonism of the compound, normalized to the activity of VUAA1.

c

Entire ring replaced.